Latest
1752vc1752vc|Deviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech StartupsDeviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech Startups|ParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology TherapiesParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology Therapies|DISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer RetentionDISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer Retention|a16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructurea16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructure|Restive Ventures Raises $45M Fund III to Back AI-Native Financial Services StartupsRestive Ventures Raises $45M Fund III to Back AI-Native Financial Services Startups|5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services|Pit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise OperationsPit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise Operations|Lunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure SystemsLunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure Systems|Anagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic FibrosisAnagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic Fibrosis|1752vc1752vc|Deviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech StartupsDeviation Capital Launches with $2B AUM to Back AI, Robotics, and Deep Tech Startups|ParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology TherapiesParcelBio Raises $13M Seed to Advance Durable mRNA Platform for Autoimmune and Oncology Therapies|DISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer RetentionDISHIO Raises $2.5M Seed to Power AI-Driven Restaurant Marketing and Customer Retention|a16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructurea16z Crypto Launches $2.2B Fund to Invest in Blockchain and Financial Infrastructure|Restive Ventures Raises $45M Fund III to Back AI-Native Financial Services StartupsRestive Ventures Raises $45M Fund III to Back AI-Native Financial Services Startups|5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services5th Century Partners Closes $276M Fund II to Invest in Lower Middle Market Healthcare and Services|Pit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise OperationsPit Raises $16M Seed to Build AI-Driven Internal Systems for Enterprise Operations|Lunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure SystemsLunar Outpost Raises $30M Series B to Scale Lunar Mobility and Space Infrastructure Systems|Anagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic FibrosisAnagram Secures $250M to Develop Next-Generation Enzyme Therapy for Cystic Fibrosis
Back to articles

Collide Capital Raises $95M Fund II to Back Early-Stage Startups in Fintech, Supply Chain, and Future of Work

Capital doesn’t knock politely in this game. It moves fast, finds conviction, and settles where the signal is loudest. Collide Capital just pulled $95M into Fund II, and now the room is paying attention whether it planned to or not.

Brian Hollins and Aaron Samuels didn’t walk into this game with a silver spoon and a pitch deck full of buzzwords. They built Collide Capital from a two-person experiment into a firm that now commands over $170M in assets under management, punctuated by a freshly closed $95M Fund II that didn’t just fill up, it overflowed.

That kind of oversubscription is not luck. That is signal. The kind institutional LPs listen to when deciding where the next decade gets financed. University of California endowment, Accolade Partners, Fairview Capital, Goldman Sachs, JPMorgan. That room does not clap for potential. It writes checks for precision.

Collide Capital lives in the spaces most people claim to understand but rarely touch with conviction. Fintech that actually moves money and infrastructure, not just interfaces. Supply chains that do more than survive headlines. The future of work that shows up in revenue, not just conference panels. From pre seed through Series A, writing $1M to $3M checks, they are placing bets early enough to matter and structured enough to scale.

More than 75 companies in the portfolio and 5 exits on the board, self reported but still telling a story. Not of volume, but of velocity. You do not get there by playing it safe. You get there by seeing around corners while everyone else is still arguing about the map.

And here is where it gets interesting. Collide is not just deploying capital. They are engineering access. Fortune 500 pathways. Cloud relationships with Amazon, Microsoft, Alphabet, Anthropic. Financial rails through JPMorgan, Silicon Valley Bank, Stifel. This is less about writing checks and more about wiring companies directly into the system they are trying to disrupt.

There is a quiet power in the name Collide. It is not chaos. It is convergence. Capital meets capability. Founders meet infrastructure. Ideas meet execution at full speed. Brian Hollins and Aaron Samuels are not chasing trends. They are positioning themselves where markets have no choice but to meet them. And when capital, access, and timing collide like that, the outcome is rarely subtle and never accidental.